A new educational program in heart failure drug development-Reference-Cited by-同舟云学术

A new educational program in heart failure drug development

Published:2018-08 Issue:8 Volume:19 Page:411-421
ISSN:1558-2027
Container-title:Journal of Cardiovascular Medicine
language:en
Short-container-title:Journal of Cardiovascular Medicine

Author:

Dungen Hans-Dirk,Petroni Renata,Correale Michele,Coiro Stefano,Monitillo Francesco,Triggiani Marco,Leone Marta,Antohi Elena-Laura,Ishihara Shiro,Sarwar Chaudhry M.S.,Sabbah Hani N.,Memo Maurizio,Metra Marco,Butler Javed,Nodari Savina,Gheorghiade Mihai

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference44 articles.

1. Global Public Health Burden of Heart Failure

2. Forecasting the Impact of Heart Failure in the United States

3. Current trends in heart failure readmission rates: analysis of medicare data

4. Recent National Trends in Readmission Rates After Heart Failure Hospitalization

5. Strategies to Reduce Heart Failure Readmissions—Reply

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance of delirium in patients with heart failure: a systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2023-08-11

2. Value of FT3/FT4 Ratio in Prognosis of Patients With Heart Failure: A Propensity-Matched Study;Frontiers in Cardiovascular Medicine;2022-04-12

3. Predictive Value of the Serum Cystatin C/Prealbumin Ratio in Combination With NT-proBNP Levels for Long-Term Prognosis in Chronic Heart Failure Patients: A Retrospective Cohort Study;Frontiers in Cardiovascular Medicine;2021-07-14

4. Liver disease and heart failure;Panminerva Medica;2020-03

5. Short-Term Therapies for Treatment of Acute and Advanced Heart Failure—Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?;Journal of Clinical Medicine;2019-11-01